|
|
News Breaks | | | | September 5, 2012 | | 06:32 EDT |  | PCRX | Pacira Pharma reports results comparing Exparel with Bupivacaine HCI
Pacira Pharmaceuticals announced the publication of results from a pooled analysis of nine clinical trials across five surgical models that compared cumulative pain scores, opioid consumption and occurrence of opioid-related adverse events following administration of EXPAREL or bupivacaine HCl. Notably, the results of the pooled analysis demonstrated that EXPAREL in a multimodal setting was associated with a statistically significant reduction in cumulative pain scores through 72 hours nad longer time to first opioid rescue. | |
|
News For PCRX From The Last 14 Days Check below for free stories on PCRX the last two weeks. |
|
|
| There are no results for PCRX |
|
|
|
|
|
|
